Exicure (XCUR) Other Non Operating Income (2016 - 2025)
Exicure's (XCUR) quarterly Other Non Operating Income came in at $127000.0 in Q4 2025, up 370.37% on a QoQ basis from $27000.0 in Q3 2025.
Exicure (XCUR) Other Non Operating Income (2016 - 2025) Analysis & Trends
Exicure (XCUR) has 10 years of Other Non Operating Income data on file, last reported at $127000.0 in Q4 2025.
- Quarterly Other Non Operating Income changed N/A year-over-year to $127000.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $206000.0 (down 90.45% YoY) and the FY2025 annual result came in at $107000.0, up 2040.0% from the prior year.
- Other Non Operating Income rose to $127000.0 in Q4 2025, from $27000.0 in the prior quarter.
- In the past five years, Other Non Operating Income ranged from a high of $1.5 million in Q3 2024 to a low of -$150000.0 in Q2 2023.
- A 5-year average of $123105.3 and a median of $7000.0 in 2023 frame the typical range for Other Non Operating Income.
- Annual changes were most pronounced in 2023 — Other Non Operating Income plunged 3650.0% — and 2024, when it surged 1548.35%.
- Tracing XCUR's Other Non Operating Income over 5 years: stood at $3000.0 in 2021, then slumped by 3400.0% to -$99000.0 in 2022, then soared by 107.07% to $7000.0 in 2023, then soared by 21328.57% to $1.5 million in 2024, then tumbled by 91.53% to $127000.0 in 2025.
- The last three Other Non Operating Income figures came in at $127000.0 (Q4 2025), $27000.0 (Q3 2025), and $52000.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Exicure | 7.27 Mn | 7.27 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 127,000.00 |
| Sep 30, 2025 | 27,000.00 |
| Jun 30, 2025 | 52,000.00 |
| Mar 31, 2025 | 27,000.00 |
| Sep 30, 2024 | 1.50 Mn |
| Jun 30, 2024 | 631,000.00 |
| Mar 31, 2024 | 4,000.00 |
| Dec 31, 2023 | 7,000.00 |
| Sep 30, 2023 | 91,000.00 |
| Jun 30, 2023 | -150,000.00 |
| Mar 31, 2023 | 104,000.00 |
| Dec 31, 2022 | -99,000.00 |
| Sep 30, 2022 | 41,000.00 |
| Jun 30, 2022 | -4,000.00 |
| Mar 31, 2022 | -20,000.00 |
| Dec 31, 2021 | 3,000.00 |
| Sep 30, 2021 | -5,000.00 |
| Jun 30, 2021 | 2,000.00 |
| Mar 31, 2021 | 1,000.00 |
| Dec 31, 2020 | 51,000.00 |